Close Menu

SAIC-Frederick

The company will develop the cancer-targeted antibodies for SAIC-Frederick under an NCI proteomics initiative.

The new building will house a wide range of advanced research and development technologies — from biopharmaceutical development and manufacturing to genomics and nanotechnology — that ATPI partners can access by collaborating with NCI.

According to the solicitation, caBIG is seeking a contractor who can "maintain and enhance all components of caB2B in terms of functionality and usability along with maintainability, security, and performance through focused refactoring."

The NCI contractor will use Roche's sequence capture technology and FLX sequencer on cancer genomics tests.

Pages

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.